Clinical Pharmacy A Sliver of the Liver: Key Concepts in Hepatic Function The liver, often overlooked alongside the kidneys, is a vital organ for metabolizing medications and toxins, producing bile to emulsify fats, and storing energy as glycogen, among many other functions.
Health and Wellness The Return of Ranitidine Ranitidine (Zantac) returns after NDMA-related recall, with reformulation aimed at improving safety while maintaining GERD treatment efficacy.
Clinical Pharmacy Feeling Better Isn't Enough: Why You Should Always Finish Your Antibiotic Prescription More than 2.8 million infections from antibiotic-resistant bacteria occur in the United States each year, resulting in ~35,000 deaths.
Students YFP Gives Scholarship 2026 Your Financial Pharmacist Gives scholarships are LIVE and accepting applications for 2026!
Pharmacy Industry The Role of Digital Twins in Drug Development Digital twins transform pharma by simulating trials, predicting failures, and optimizing manufacturing for faster, safer drug development.
Clinical Pharmacy Acute Multiple Sclerosis Exacerbation: A Quick Overview Although the precise cause of MS remains unclear, current evidence suggests that the disease develops when genetically susceptible individuals encounter environmental triggers that initiate immune-mediated damage within the central nervous system
Paid-members only Monthly Recaps February Recap 2026 We are back with another monthly post for our paid subscribers. In this post, we also share several fun things that are more personal, interesting, and meant to create a closer community around RxTeach
Clinical Pharmacy The Anti-Smoking Antidepressant Bupropion’s dopamine and norepinephrine effects reduce nicotine cravings, explaining its FDA approval as a first-line smoking cessation aid now.
Pharmacy Industry Medical Science Liaison: A Day in the Life The MSL position comes with great flexibility, work-life balance, compensation, benefits, travel to interesting places, and a sense of expertise in your given field.
Pharmacy Industry The Consolidated Appropriations Act of 2026 The 2026 Consolidated Appropriations Act reforms PBM compensation, boosts transparency, and may reshape U.S. drug pricing strategies nationwide.
Health and Wellness The New Food Pyramid The new dietary guidelines are an incredible improvement upon the previous version of the food pyramid.
Paid-members only Monthly Recaps January Recap 2026 We are back with another monthly post for our paid subscribers. In this post, we also share a number of fun things that are more personal, interesting, and meant to create a closer community around RxTeach.
Members only Clinical Pharmacy OASIS-4 Journal Club Journal club review of the OASIS-4 trial evaluating oral semaglutide 25 mg for weight loss, including efficacy, safety outcomes, and clinical impact.
Pharmacy Industry The Importance of a Value Proposition Why great drugs fail without a story: how pharma value propositions turn clinical data into stakeholder-specific impact and market access.
Clinical Pharmacy Hypervolemic Hyponatremia Hyponatremia in hypervolemic patients explained: risks in older adults, safe sodium correction, and treatment options including loop diuretics and vaptans.
Students Health Literacy Is a Public Health Emergency in the South: What Student Pharmacists Can Do Now Start early. Start now. Start for the reason you chose this profession, to improve patients’ health and change lives through understanding.
Health and Wellness Progress Isn't Perfect Perseverance is the most important factor in achieving any goal, despite the setbacks or less-than-ideal weeks.
Clinical Pharmacy The Andexxa Paradox Andexxa withdrawn after ANNEXA-I showed higher stroke risk; clinicians return to 4F-PCC for DOAC reversal while new agents emerge.
Paid-members only Monthly Recaps December Recap 2025 We are back with another monthly post for our paid subscribers. In this post, we also share a number of fun things that are more personal, interesting, and meant to create a closer community around RxTeach.
Kaplan-Meier Curves in Oncology Introduction Kaplan-Meier (KM) survival curves are foundational to oncology clinical trials and can be central to how efficacy is assessed for cytotoxic chemotherapy, targeted therapies, immunotherapies, and cellular therapies. Endpoints such as overall survival (OS), progression-free survival (PFS), event-free survival (EFS), and duration of response (DoR) are almost universally presented